Studies evaluating GR expression in human surgically removed pituitary adenomas using a polyclonal GR antibody, and it also revealed nuclear and/or cytoplasmic GR immunoreactivity in many non-tumorous corticotrophs and other adenohypophysial cell types [12]. Here, NR3C1 is linked to pituitary gland adenoma.